German  |  English
Features for this Premium Statistic
 

Do you have a question or a suggestion for this statistic? Please visit our contact page.
More statistics about...
 
You may also be interested in...
 
We are celebrating
 
International Year of Statistics 2013Statistics have powerful and far-reaching effects on everyone, yet most people are unaware of their connection and how statistics improve their lives. 2013 is the International Year of Statistics, a worldwide event supported by nearly 1,900 organizations - and we are part of it!learn more
Recommended Websites
 

Do you know of an interesting website related to this topic? Suggest here

Novartis: Spending on research and development (fee-based)

 

Novartis: Spending on research and development by division from 2008 to 2010 (in billion U.S. dollars)

Do you want to view this graph? Sign up for a Premium Account and benefit from the following extras:

  • Quick and convenient access to all statistics
  • More than 1.5 million statistics and facts
  • All data downloadable in PPT, XLS and JPG format

Get Account Source Get Account


© Statista 2013

Reading support:
This statistic represents the expenditure on research and development of the pharmaceutical company Novartis from 2008 to 2010 by business segment. In 2008, the company spent around 5.7 billion U.S. dollars for research and development in the Pharmaceuticals Division.

Statistic Information
 
Survey
Survey by  Get Account
Survey name  Get Account
Survey time period 2008 to 2010
Object of investigation Expenditure on research and development of the pharmaceutical company Novartis
Region Worldwide
Macroregion Trans-Continental only (with GER)
Type Ranking
Category capital asset/cost
Relevance 2
Release
Published by  Get Account
Source link  Get Account
Release date March 2011
Further information  Get Account
Popular statistics
 
Viewed by other users
 
Latest statistics
 
Related reports
 
to: expenditure, Novartis
How you can access Statista